Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
Patricia Udaondo1,2, Salvador Garcia-Delpech1,3, David Salom1,3, Maria Garcia-Pous1,3, Manuel Diaz-Llopis1,31Nuevo Hospital Universitario y Politecnico La Fe, Valencia, Spain; 2University Cardenal Herrera CEU, Valencia, Spain; 3Faculty of Medicine, University of Valencia, Valencia, SpainPurpose: To...
Main Authors: | Udaondo P, Garcia-Delpech S, Salom D, Garcia-Pous M, Diaz-Llopis M. |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-07-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/intravitreal-pegaptanib-for-refractory-macular-edema-secondary-to-reti-a7821 |
Similar Items
-
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
by: Kiire CA, et al.
Published: (2015-12-01) -
Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01) -
Short-term efficacy of intravitreal triamcinolone acetonide for macular edema secondary to retinal vein occlusion that is refractory to intravitreal bevacizumab
by: Seul Gi Yoo, et al.
Published: (2015-01-01) -
Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
by: Juan Carlos Mesa Gutiérrez, et al.
Published: (2008-09-01) -
Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
by: Paulose R, et al.
Published: (2016-09-01)